Stock Earnings

Question 1

What are Dr. Reddy's Laboratories Limited's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Dr. Reddy's Laboratories Limited has a total asset of $0, Net profit of $41,960

Question 2

What are the key financial ratios for RDY?

Accepted Answer

Dr. Reddy's Laboratories Limited's Current ratio is 0, has a Net margin is 12.45, sales per share of $404.38.

Question 3

How is Dr. Reddy's Laboratories Limited's revenue broken down by segment or geography?

Accepted Answer

Dr. Reddy's Laboratories Limited largest revenue segment is Global Generics, at a revenue of 289,552,000,000 in the most earnings release.For geography, United States is the primary market for Dr. Reddy's Laboratories Limited, at a revenue of 149,351,000,000.

Question 4

Is Dr. Reddy's Laboratories Limited profitable?

Accepted Answer

yes, according to the latest financial statements, Dr. Reddy's Laboratories Limited has a net profit of $41,960

Question 5

Does Dr. Reddy's Laboratories Limited have any liabilities?

Accepted Answer

no, Dr. Reddy's Laboratories Limited has liability of 0

Question 6

How many outstanding shares for Dr. Reddy's Laboratories Limited?

Accepted Answer

Dr. Reddy's Laboratories Limited has a total outstanding shares of 0

Breakdown	TTM	03/31/2026	03/31/2025	03/31/2024	03/31/2023	03/31/2022
Revenue	337,002	337,002	326,439	280,111	246,697	215,452
Revenue Growth (YoY)	3%	3%	17%	14%	15%	13%
Cost of Revenue	122,392	122,392	107,834	89,398	83,048	79,972
Gross Profit	214,610	214,610	218,605	190,713	163,649	135,480
Selling, General & Admin	59,909	58,739	107,560	92,026	82,048	73,399
Research & Development	--	--	23,881	19,353	16,201	15,100
Operating Expenses	167,086	165,846	148,478	126,079	110,751	100,151
Other Non Operating Income (Expenses)	11,694	12,184	1,908	2,342	6,289	657
Pretax Income	53,927	53,927	76,795	72,010	60,485	30,614
Income Tax Expense	12,351	12,351	19,543	16,231	15,412	8,833
Net Income	41,960	41,960	56,551	55,779	45,073	21,825
Net Income Growth	-26%	-26%	1%	24%	107%	12%
Shares Outstanding (Diluted)	833.58	833.36	834.17	833.53	831.94	831.69
Shares Change (YoY)	0%	0%	0%	0%	0%	401%
EPS (Diluted)	50.33	50.35	67.79	66.91	54.17	26.24
EPS Growth	-26%	-26%	1%	24%	106%	-78%
Free Cash Flow	18,332	18,332	12,030	17,998	40,009	9,059
Free Cash Flow Per Share	21.99	21.99	14.42	21.59	48.09	10.89
Gross Margin	63.68%	63.68%	66.96%	68.08%	66.33%	62.88%
Operating Margin	14.1%	14.46%	21.48%	23.07%	21.44%	16.39%
Profit Margin	12.45%	12.45%	17.32%	19.91%	18.27%	10.12%
Free Cash Flow Margin	5.43%	5.43%	3.68%	6.42%	16.21%	4.2%
EBITDA	68,112	69,352	87,164	79,334	65,400	46,981
EBITDA Margin	20.21%	20.57%	26.7%	28.32%	26.51%	21.8%
D&A For EBITDA	20,588	20,588	17,037	14,700	12,502	11,652
EBIT	47,524	48,764	70,127	64,634	52,898	35,329
EBIT Margin	14.1%	14.46%	21.48%	23.07%	21.44%	16.39%
Effective Tax Rate	22.9%	22.9%	25.44%	22.53%	25.48%	28.85%

Dr. Reddy's Laboratories Limited (RDY) Price

RDY Stock Price Chart

RDY Income

Follow-Up Questions